- Quantity
- 5 mg per vial
- CAS
- 221231-10-3
- Mol. weight
- 1815.1 g/mol
- Formula
- C78H123N23O23S2
- Current lot
- AO-2609-01
AOD-9604 Lyophilized Powder, 5 mg Vial, ≥99% HPLC
- Quantity per vial5 mg
- FormLyophilized powder
- Purity≥99% by HPLC
- Identity methodMass spectrometry
$99.99
AOD-9604, 5 mg lyophilized powder per vial, ≥99% by HPLC with identity by mass spectrometry. Lot-specific certificate of analysis available for download.
120 in stock
- Purity (HPLC)
- 99.8%
- Quantity
- 5 mg per vial
- Form
- Lyophilized powder in a sealed 3 mL glass vial
- Molecular formula
- C78H123N23O23S2
- Molecular weight
- 1815.1 g/mol
- CAS number
- 221231-10-3
- Storage
- Lyophilized powder: store sealed at -20 °C, protected from light and moisture. Ships at ambient temperature with desiccant.
For laboratory research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not for human consumption. Sold to qualified researchers and institutions for in-vitro research. Handle in accordance with your institution's safety guidelines.
AO-2609-01- -20 °Cstore sealed, frozen
- Lightprotect from light
- Drydesiccant, keep dry
- 1Packed coldSealed vial, insulated mailer, desiccant
- 2Shipped trackedNext business day
- 3Straight to the freezerLog the lot against the certificate
Vial content and diluent volume → concentration, volume per draw and insulin-syringe units (U-100).
- Concentration
- —
- Volume per draw
- —
- Syringe units (U-100)
- —
- Draws per vial
- —
Laboratory preparation arithmetic (1 mL = 100 units on a U-100 syringe). No guidance on use. For laboratory research only; not for human or veterinary use.
Also known as: AOD 9604; hGH fragment 176-191 All listings for CAS 221231-10-3 →
Compare: vs BPC-157 Lyophilized Powder, 10 mg per Vial · vs BPC-157 Lyophilized Powder, 5 mg Vial · vs CJC-1295 with DAC 5 mg Lyophilized Vial · What HPLC, MS and CoA mean →
- Orders over $100−5%
SAVE5 - Orders over $200−10%
SAVE10
AOD-9604 is a synthetic 16-amino-acid fragment (residues 176–191) of human growth hormone with an N-terminal tyrosine, supplied as a lyophilized powder at 5 mg per vial. Purity is ≥99% by HPLC, with identity confirmed by mass spectrometry, and a lot-specific certificate of analysis is available for download. The compound is sold for research use only.
Why the ≥99% HPLC figure and the CAS number matter
Purity paired with method
Purity is stated as ≥99% by HPLC, not as a generic grade. The figure and the method appear together on the certificate of analysis for the lot shipped.
Identity confirmation
Mass spectrometry confirms the identity of the 16-amino-acid fragment. That places a second, independent check alongside the chromatographic purity figure.
Catalogue identifiers
Molecular formula C78H123N23O23S2, molecular weight 1815.1 g/mol and CAS 221231-10-3 allow a purchasing officer to match this entry against an internal reagent record.
Single quantity
The vial contains 5 mg of lyophilized powder. No other fill size is offered, so larger quantities require multiple vials.
Lot traceability
Each certificate of analysis is lot-specific. Documentation can be filed against the lot number recorded in the laboratory inventory.
Specifications of the 5 mg AOD-9604 vial
- Identity
- Synthetic 16-amino-acid fragment (residues 176–191) of human growth hormone, N-terminal tyrosine
- Quantity per vial
- 5 mg
- Form
- Lyophilized powder
- Purity
- ≥99% by HPLC
- Identity method
- Mass spectrometry
- Molecular formula
- C78H123N23O23S2
- Molecular weight
- 1815.1 g/mol
- CAS number
- 221231-10-3
- Ships from
- Richmond, BC
- Packaging
- Insulated mailer with desiccant, ambient temperature
- Shipping weight
- 0.05 kg packed
- Package dimensions
- 8×8×6 cm
- Price
- $99.99 CAD
Who the 5 mg fill suits
The 5 mg vial fits a laboratory running a short in-vitro series on a single fragment, and it fits a purchasing officer adding one documented reagent line to an existing order. Laboratories needing a larger working quantity should order several vials, since 5 mg is the only fill offered.
Storage: lyophilized powder, sealed, at -20 °C, protected from light and moisture. Shipping is at ambient temperature with desiccant, from Richmond, BC. A lot-specific certificate of analysis stating identity, purity and test method is available for download. For laboratory research use only. Not for human or veterinary use.
Common questions
Does each vial come with a certificate of analysis?
Yes. Each lot ships with a downloadable lot-specific certificate of analysis stating ≥99% purity by HPLC, with identity confirmed by mass spectrometry.
How much AOD-9604 is in a vial?
Each vial contains 5 mg of AOD-9604 as a lyophilized powder. Molecular formula C78H123N23O23S2, molecular weight 1815.1 g/mol, CAS 221231-10-3.
How should the lyophilized powder be stored, and how does it ship?
Store the sealed vial at -20 °C, protected from light and moisture. It ships at ambient temperature from Richmond, BC in an insulated mailer with desiccant, for research use only. For laboratory research use only. Not for human or veterinary use.
How it compares
AOD-9604 Lyophilized Powder, 5 mg Vial, ≥99% HPLC next to TB-500 Lyophilized Powder, 10 mg Vial, ≥99% HPLC ($30.00 more) and BPC-157 Lyophilized Powder, 10 mg per Vial ($5.00 less).
| AOD-9604 Lyophilized Powder, 5 mg Vial, ≥99% HPLC this page | TB-500 Lyophilized Powder, 10 mg Vial, ≥99% HPLC | BPC-157 Lyophilized Powder, 10 mg per Vial | |
|---|---|---|---|
| Price | $99.99 | $129.99 | $94.99 |
| Quantity | 5 mg per vial | 10 mg per vial | 10 mg per vial |
| Purity | 99.8% (HPLC) | 99.7% (HPLC) | 99.7% (HPLC) |
| Molecular weight | 1815.1 g/mol | 889.0 g/mol | 1419.5 g/mol |
| Formula | C78H123N23O23S2 | C38H68N10O14 | C62H98N16O22 |
| CAS | 221231-10-3 | 77591-33-4 | 137525-51-0 |
| Form | Lyophilized powder in a sealed 3 mL glass vial | Lyophilized powder in a sealed 3 mL glass vial | Lyophilized powder in a sealed 3 mL glass vial |
Peer-reviewed literature
Journal articles indexed in PubMed for AOD-9604. Provided as bibliographic reference only; they do not describe this product or any use of it.
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsPMID 41490200DOI 10.5435/JAAOSGlobal-D-25-00236
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformancePMID 41966639DOI 10.1007/s40279-026-02437-0
- AOD-9604 MetabolicPMID 15134286
- Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer CellsPMID 35783198DOI 10.2147/DDDT.S367586
Read before you buy
Last updated September 23, 2026
